Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Improvements in Work Productivity With Up to 104 Weeks of Apremilast Monotherapy: Results From a Phase 3b, Randomized, Controlled Study in Biologic-Naïve Subjects With Active Psoriatic Arthritis. World Psoriasis & Psoriatic Arthritis Conference (WPPAC) by International Federation of Placenta Associations (IFPA), Stockholm, Sweden, July 2018.
International Federation of Placenta Associations (IFPA) (2018)
  • Philip Mease, Providence St. Joseph Health
  • Dafna D. Gladman, University of Toronto
  • EK Davenport
Link
Disciplines
Publication Date
July, 2018
Location
Stockholm
Citation Information
Philip Mease, Dafna D. Gladman and EK Davenport. "Improvements in Work Productivity With Up to 104 Weeks of Apremilast Monotherapy: Results From a Phase 3b, Randomized, Controlled Study in Biologic-Naïve Subjects With Active Psoriatic Arthritis. World Psoriasis & Psoriatic Arthritis Conference (WPPAC) by International Federation of Placenta Associations (IFPA), Stockholm, Sweden, July 2018." International Federation of Placenta Associations (IFPA) (2018)
Available at: http://works.bepress.com/philip-mease/123/